CRISPR
Startup CrisprBits Forms Strategic Collaboration With MolBio Diagnostics
The Indian firms will partner to accelerate manufacturing and distribution of CRISPR-based point-of-care diagnostics for pathogens and genetic markers.
The firm has a handful of beta users of the assay design tool but has not previously publicly disclosed its strategy to make the method broadly available.
The firm reported Thursday its Q1 revenues declined 30 percent as COVID-19 revenues dwindled but non-COVID organic revenues grew 6 percent.
The firm now anticipates accelerating its commercialization phase by one to two years and will mix and match its technologies going forward.
Sherlock Biosciences to Acquire Sense Biodetection
The firms intend to combine Sherlock's CRISPR technology and Sense's rapid molecular amplification chemistries, accelerating Sherlock's go-to-market strategy.
Sep 2, 2022
May 31, 2022
Aug 10, 2021
Jun 29, 2021